Psychiatry Research
Volume 135, Issue 2 , Pages 91-101 , 15 June 2005

Abnormal subjective experiences of schizophrenia: Evaluation of the Eppendorf Schizophrenia Inventory

  • Reinhard Mass

      Affiliations

    • Center of Mental Health, Leppestr. 65-67, 51709 Marienheide, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 2264 24 140/143; fax: +49 2264 24 181.
    • ,
  • Christian Haasen

      Affiliations

    • University Hospital Eppendorf, Psychiatric Clinic, Hamburg, Germany
    • ,
  • Ernst-Jürgen Borgart

      Affiliations

    • Psychosomatic Clinic, Bad Pyrmont, Germany

Received 11 October 2003 ,Accepted 25 August 2004.

References 

  1. Arbuckle JL. AMOS User's Guide, Version 4.01. Chicago: Small Waters Corporation; 1999;
  2. Brown MW, Cudeck R. Alternative ways of assessing model fit. In:  Bollen K,  Long JS editor. Testing Structural Equation Models. Newbury Park, CA: Sage; 1993;p. 136–162
  3. Byne W, Davis KL. The role of prefrontal cortex in the dopaminergic dysregulation of schizophrenia. Biological Psychiatry. 1999;45:657–659
  4. Chapman LJ, Chapman JP, Raulin ML. Body-image aberration in schizophrenia. Journal of Abnormal Psychology. 1978;87:399–407
  5. Chen EYH, Lam LCW, Chen RYL, Nguyen DGH, Kwok CL, Au JWY. Neurological signs and sustained attention impairment in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 2001;251:1–5
  6. Cuesta MJ, Peralta V, Juan JA. Abnormal subjective experiences in schizophrenia: its relationships with neuropsychological disturbances and frontal signs. European Archives of Psychiatry and Clinical Neuroscience. 1996;246:101–105
  7. Gaebel W, Frick U, Köpcke W, Linden M, Müller P, Müller-Spahn F, et al. Early neuroleptic intervention in schizophrenia: are prodromal symptoms valid predictors of relapse?. British Journal of Psychiatry. 1993;163:8–12
  8. Galeazzi GM, Spiliopulos P, Curci P. Eppendorf Schizophrenia Inventory (ESI): presentazione della versione italiana. Italian Journal of Psychopathology. 2004;10:322–330
  9. Herz MI, Lamberti JS. Prodromal symptoms and relapse prevention in schizophrenia. Schizophrenia Bulletin. 1995;21:541–551
  10. Hiller W, Zaudig M, Mombour W. IDCL, Internationale Diagnosen-Checklisten für ICD-10 und DSM-IV. Bern: Huber; 1995;
  11. Horn W. Leistungsprüfsystem L-P-S. Handanweisung für die Durchführung, Auswertung und Interpretation. Göttingen: Verlag für Psychologie Dr. C.J. Hogrefe; 1962;
  12. Hümmeler V, Stöhr K, Jahn T. Subjektives Erleben perzeptiv-kognitver Symptome bei schizophrenen Patienten: Zusammenhang mit mnestischen Defiziten und Psychopathologie. Zeitschrift für Klinische Psychologie, Psychiatrie und Psychotherapie. 2005;53:129–142
  13. Ismail B, Cantor-Graae E, McNeil TF. Neurological abnormalities in schizophrenic patients and their siblings. American Journal of Psychiatry. 1998;155:84–89
  14. Jahn T, Mussgay L. Die statistische Kontrolle möglicher Medikamenteneinflüsse in experimentalpsychologischen Schizophreniestudien, Ein Vorschlag zur Berechnung von Chlorpromazinäquivalenten. Zeitschrift für Klinische Psychologie. 1989;18:257–267
  15. Jørgensen P. Early signs of psychotic relapse in schizophrenia. British Journal of Psychiatry. 1998;172:327–330
  16. Karr M, Schröder J, Tittel A. Neurologische soft signs und neuropsychologische Störungen bei schizophrenen Psychosen. Nervenheilkunde. 1996;15:326–331
  17. Kathmann N, Wagner M, Satzger W, Engel RR. Vigilanzmessung auf Verhaltensebene, Der Continuous Performance Test-München (CPT-M). In:  Möller HJ,  Engel RR,  Hoff P editor. Befunderhebung in der Psychiatrie, Lebensqualität, Negativsymptomatik und andere aktuelle Entwicklungen. Wien: Springer; 1996;p. 331–338
  18. Kay SR, Opler LA, Fiszbein A. Significance of positive and negative syndromes in chronic schizophrenia. British Journal of Psychiatry. 1986;149:439–448
  19. Klosterkötter J, Ebel H, Schultze-Lutter F, Steinmeyer EM. Diagnostic validity of basic symptoms. European Archives of Psychiatry and Clinical Neuroscience. 1996;246:147–154
  20. Klosterkötter J, Schultze-Lutter F, Gross G, Huber G, Steinmeyer EM. Early self-experienced neuropsychological deficits and subsequent schizophrenic diseases: an 8-year average follow-up prospective study. Acta Psychiatrica Scandinavica. 1997;95:396–404
  21. Liddle PF, Barnes TRE. The subjective experience of deficits in schizophrenia. Comprehensive Psychiatry. 1988;29:157–164
  22. Loong JWK. The Wisconsin Card Sorting Test. San Luis Obispo, CA: Wang Neuropsychological Laboratory; 1990;
  23. Mass R. Characteristic subjective experiences of schizophrenia. Schizophrenia Bulletin. 2000;26:921–931
  24. Mass R. Das Vigilanzparadigma in der Schizophrenieforschung. Untersuchungen zum Continuous Performance Test (CPT). Fortschritte der Neurologie und Psychiatrie. 2002;70:34–39
  25. Mass R, Haasen C, Krausz M. Dimensional structure and diagnostic specificity of the Frankfurt Complaint Questionnaire. European Psychiatry. 1997;12:117–123
  26. Mass R, Schömig T, Hitschfeld K, Wall E, Haasen C. Psychopathological syndromes of schizophrenia. Evaluation of the dimensional structure of the Positive and Negative Syndrome Scale (PANSS). Schizophrenia Bulletin. 2000;26:167–177
  27. Mass R, Schömig T, Novikov J, Wagner M. Effects of cerebral hemispheric laterality on the span of apprehension of schizophrenic and healthy subjects. European Archives of Psychiatry and Clinical Neuroscience. 2001;251:18–23
  28. McGorry PD, Yung A, Phillips L. Ethics and early intervention in psychosis, keeping up the pace and staying in step. Schizophrenia Research. 2001;51:17–29
  29. Møller P, Husby R. The initial prodrome in schizophrenia, searching for naturalistic core dimensions of experience and behaviour. Schizophrenia Bulletin. 2000;26:217–232
  30. Mundt C, Kasper S, Huerkamp M. The diagnostic specificity of negative symptoms and their psychopathological context. British Journal of Psychiatry. 1989;155(7):32–36
  31. Nakaya M, Kusumoto K, Ohmori K. Subjective experience of Japanese inpatients with chronic schizophrenia. Journal of Nervous and Mental Disease. 2002;190:80–85
  32. Norman RMG, Malla AK, Morrison-Stewart SL, Helmes E, Williamson PC, Thomas J, et al. Neuropsychological correlates of syndromes in schizophrenia. British Journal of Psychiatry. 1997;170:134–139
  33. Posner MI, Rafal RD. Cognitive theories of attention and the rehabilitation of attentional deficits. In:  Meier RJ,  Benton AC,  Diller L editor. Neuropsychological Rehabilitation. Edinburgh: Churchill Livingstone; 1987;
  34. Reitan RM. Trail Making Test. Manual for Administration and Scoring. Tucson, AZ: Reitan Neuropsychology Laboratory; 1992;
  35. Scherbarth-Roschmann P, Hautzinger M. Zur psychometrischen Erfassung von Schizotypie. Methodische Überprüfung und erste Validierung von zwei Skalen zur Erfassung von Risikomerkmalen. Zeitschrift für Klinische Psychologie. 1991;20:238–250
  36. Schröder J, Niethammer R, Geider F-J, Reitz C, Binkert M, Jauss M, et al. Neurological soft signs in schizophrenia. Schizophrenia Research. 1992;6:25–30
  37. Society for Neuropsychology, Germany . Working group “Attention and Memory”. Questionnaire of Subjective Experiences of Attention Deficits (Fragebogen erlebter Defizite der Aufmerksamkeit, FEDA). 1997;
  38. Tewes, U., 1991. HaWIE-R. Hamburg-Wechsler Intelligenztest für Erwachsene. Revision 1991. Verlag Hans Huber, Bern, Stuttgart, Toronto.
  39. Tucker G, Harrow M, Detre T, Hoffmann B. Perceptual experiences in schizophrenic and nonschizophrenic patients. Archives of General Psychiatry. 1969;20:159–166
  40. van den Bosch RJ, Rozendaal N. Subjective cognitive dysfunction, eye tracking, and slow brain potentials in schizophrenic and schizoaffective patients. Biological Psychiatry. 1988;24:741–746
  41. Venables PH. Cognitive and attentional disorders in the development of schizophrenia. In:  Häfner H,  Gattaz WF,  Janzarik W editor. Search for the Causes of Schizophrenia. Berlin: Springer; 1987;p. 203–213
  42. Weinberger DR, Lipska BK. Cortical maldevelopment, antipsychotic drugs, and schizophrenia: a search for common ground. Schizophrenia Research. 1995;16:87–110
  43. Zerssen Dv. Paranoid-Depressivitäts-Skala. Depressivitäts-Skala. Manual. Weinheim: Beltz; 1976;

PII: S0165-1781(05)00101-0

doi: 10.1016/j.psychres.2004.08.011

Psychiatry Research
Volume 135, Issue 2 , Pages 91-101 , 15 June 2005

Article Tools

* Image Usage & Resolution